Capital Advisors Ltd’s Synergy Pharmaceuticals, Inc. - Warrants SGYPW Stock Holding History

Capital Advisors Ltd’s Portfolio SGYPW Stock Details SGYPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-1,799	Closed	-$10K	–	335
2014 Q1	$10K	Hold	1,799	–	–	0.01%	272
2013 Q4	$10K	Buy	+1,799	New	+$2.96K	0.01%	241

Other funds holding SGYPW

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Capital Advisors Ltd's SGYPW Position: Q2 2014 in Review

Capital Advisors Ltd sold out of Synergy Pharmaceuticals, Inc. - Warrants (SGYPW) in Q2 2014, closing a stake of 1,799 shares — an estimated $10K sold.

Capital Advisors Ltd first reported a position in SGYPW in Q4 2013 and held it in 2 quarters. The position peaked at $10K in Q1 2014. 4 funds tracked by Wall St. Rank hold SGYPW as of Q2 2014.

Capital Advisors Ltd reported no remaining Synergy Pharmaceuticals, Inc. - Warrants position as of Q2 2014 after selling out during the quarter.
Capital Advisors Ltd sold 1,799 Synergy Pharmaceuticals, Inc. - Warrants shares in Q2 2014, an estimated $10K.
Capital Advisors Ltd first reported a position in Synergy Pharmaceuticals, Inc. - Warrants in Q4 2013 and held it in 2 quarters.
Capital Advisors Ltd's Synergy Pharmaceuticals, Inc. - Warrants position peaked at $10K in Q1 2014.
4 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc. - Warrants as of Q2 2014.

Based on Capital Advisors Ltd's 13F filing for Q2 2014, filed 23 Jul 2014.